Microsoft has partnered with ImmunityBio, Inc., a privately held immunotherapy company within the NantWorks ecosystem of companies, to leverage the company's Azure platform to perform a highly detailed computational analysis of the spike protein structure of the SARS-CoV-2, the novel coronavirus responsible for the global pandemic. The spike protein serves as the "doorway" for the […]
from MSPoweruser https://ift.tt/3bLsoz0
via IFTTT
Wednesday, April 1, 2020
Microsoft partner with ImmunityBio to unleash 24 petaflops of computing power to help develop COVID-19 vaccine
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment